Annual D&A
$11.66 M
-$70.00 K-0.60%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual depreciation & amortization is $11.66 million, with the most recent change of -$70.00 thousand (-0.60%) on December 31, 2023.
- During the last 3 years, BPMC annual D&A has risen by +$5.11 million (+77.85%).
- BPMC annual D&A is now -0.60% below its all-time high of $11.73 million, reached on December 31, 2022.
Performance
BPMC Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$3.86 M
+$246.00 K+6.80%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly depreciation & amortization is $3.86 million, with the most recent change of +$246.00 thousand (+6.80%) on September 30, 2024.
- Over the past year, BPMC quarterly D&A has increased by +$991.00 thousand (+34.51%).
- BPMC quarterly D&A is now -44.94% below its all-time high of $7.02 million, reached on December 31, 2022.
Performance
BPMC Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$13.82 M
+$991.00 K+7.72%
September 30, 2024
Summary
- As of February 7, 2025, BPMC TTM depreciation & amortization is $13.82 million, with the most recent change of +$991.00 thousand (+7.72%) on September 30, 2024.
- Over the past year, BPMC TTM D&A has dropped by -$3.33 million (-19.41%).
- BPMC TTM D&A is now -19.41% below its all-time high of $17.15 million, reached on September 30, 2023.
Performance
BPMC TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
BPMC Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.6% | +34.5% | -19.4% |
| 3 y3 years | +77.8% | +8.0% | -13.1% |
| 5 y5 years | +174.7% | +8.0% | -13.1% |
BPMC Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.6% | +80.0% | -44.9% | +162.8% | -19.4% | +116.7% |
| 5 y | 5-year | -0.6% | +121.8% | -44.9% | +162.8% | -19.4% | +162.8% |
| alltime | all time | -0.6% | +2228.3% | -44.9% | +2782.8% | -19.4% | >+9999.0% |
Blueprint Medicines Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.86 M(+6.8%) | $13.82 M(+7.7%) |
| Jun 2024 | - | $3.62 M(-24.8%) | $12.83 M(+0.3%) |
| Mar 2024 | - | $4.81 M(+214.2%) | $12.79 M(+9.7%) |
| Dec 2023 | $11.66 M(-0.6%) | $1.53 M(-46.7%) | $11.66 M(-32.0%) |
| Sep 2023 | - | $2.87 M(-19.7%) | $17.15 M(+7.9%) |
| Jun 2023 | - | $3.58 M(-2.9%) | $15.90 M(+15.3%) |
| Mar 2023 | - | $3.68 M(-47.5%) | $13.79 M(+17.5%) |
| Dec 2022 | $11.73 M(+81.1%) | $7.02 M(+332.8%) | $11.73 M(+83.9%) |
| Sep 2022 | - | $1.62 M(+10.3%) | $6.38 M(+0.1%) |
| Jun 2022 | - | $1.47 M(-9.7%) | $6.38 M(-1.9%) |
| Mar 2022 | - | $1.63 M(-2.1%) | $6.50 M(+0.3%) |
| Dec 2021 | $6.48 M(-1.2%) | $1.66 M(+2.9%) | $6.48 M(-0.1%) |
| Sep 2021 | - | $1.62 M(+1.5%) | $6.49 M(-0.5%) |
| Jun 2021 | - | $1.59 M(-1.0%) | $6.52 M(-1.2%) |
| Mar 2021 | - | $1.61 M(-3.8%) | $6.60 M(+0.6%) |
| Dec 2020 | $6.56 M(+24.7%) | $1.67 M(+1.5%) | $6.56 M(+1.5%) |
| Sep 2020 | - | $1.65 M(-1.2%) | $6.46 M(+5.8%) |
| Jun 2020 | - | $1.67 M(+6.2%) | $6.11 M(+8.0%) |
| Mar 2020 | - | $1.57 M(-0.2%) | $5.65 M(+7.5%) |
| Dec 2019 | $5.26 M | $1.57 M(+21.7%) | $5.26 M(+8.3%) |
| Sep 2019 | - | $1.29 M(+6.5%) | $4.86 M(+2.8%) |
| Jun 2019 | - | $1.21 M(+3.1%) | $4.72 M(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $1.18 M(+0.7%) | $4.64 M(+9.4%) |
| Dec 2018 | $4.25 M(+169.1%) | $1.17 M(+0.6%) | $4.25 M(+22.5%) |
| Sep 2018 | - | $1.16 M(+2.6%) | $3.47 M(+28.4%) |
| Jun 2018 | - | $1.13 M(+45.3%) | $2.70 M(+37.8%) |
| Mar 2018 | - | $780.00 K(+99.5%) | $1.96 M(+24.2%) |
| Dec 2017 | $1.58 M(-0.3%) | $391.00 K(-1.3%) | $1.58 M(-0.1%) |
| Sep 2017 | - | $396.00 K(+0.8%) | $1.58 M(-0.7%) |
| Jun 2017 | - | $393.00 K(-1.3%) | $1.59 M(-0.2%) |
| Mar 2017 | - | $398.00 K(+1.3%) | $1.59 M(+0.8%) |
| Dec 2016 | $1.58 M(+66.9%) | $393.00 K(-3.4%) | $1.58 M(+3.9%) |
| Sep 2016 | - | $407.00 K(+2.8%) | $1.52 M(+15.4%) |
| Jun 2016 | - | $396.00 K(+2.6%) | $1.32 M(+17.2%) |
| Mar 2016 | - | $386.00 K(+15.9%) | $1.13 M(+18.7%) |
| Dec 2015 | $948.00 K(+52.4%) | $333.00 K(+63.2%) | $948.00 K(+15.5%) |
| Sep 2015 | - | $204.00 K(+1.0%) | $821.00 K(+8.0%) |
| Jun 2015 | - | $202.00 K(-3.3%) | $760.00 K(+9.0%) |
| Mar 2015 | - | $209.00 K(+1.5%) | $697.00 K(+12.1%) |
| Dec 2014 | $622.00 K(+24.2%) | $206.00 K(+44.1%) | $622.00 K(+49.5%) |
| Sep 2014 | - | $143.00 K(+2.9%) | $416.00 K(+52.4%) |
| Jun 2014 | - | $139.00 K(+3.7%) | $273.00 K(+103.7%) |
| Mar 2014 | - | $134.00 K | $134.00 K |
| Dec 2013 | $501.00 K | - | - |
FAQ
- What is Blueprint Medicines annual depreciation & amortization?
- What is the all time high annual D&A for Blueprint Medicines?
- What is Blueprint Medicines annual D&A year-on-year change?
- What is Blueprint Medicines quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Blueprint Medicines?
- What is Blueprint Medicines quarterly D&A year-on-year change?
- What is Blueprint Medicines TTM depreciation & amortization?
- What is the all time high TTM D&A for Blueprint Medicines?
- What is Blueprint Medicines TTM D&A year-on-year change?
What is Blueprint Medicines annual depreciation & amortization?
The current annual D&A of BPMC is $11.66 M
What is the all time high annual D&A for Blueprint Medicines?
Blueprint Medicines all-time high annual depreciation & amortization is $11.73 M
What is Blueprint Medicines annual D&A year-on-year change?
Over the past year, BPMC annual depreciation & amortization has changed by -$70.00 K (-0.60%)
What is Blueprint Medicines quarterly depreciation & amortization?
The current quarterly D&A of BPMC is $3.86 M
What is the all time high quarterly D&A for Blueprint Medicines?
Blueprint Medicines all-time high quarterly depreciation & amortization is $7.02 M
What is Blueprint Medicines quarterly D&A year-on-year change?
Over the past year, BPMC quarterly depreciation & amortization has changed by +$991.00 K (+34.51%)
What is Blueprint Medicines TTM depreciation & amortization?
The current TTM D&A of BPMC is $13.82 M
What is the all time high TTM D&A for Blueprint Medicines?
Blueprint Medicines all-time high TTM depreciation & amortization is $17.15 M
What is Blueprint Medicines TTM D&A year-on-year change?
Over the past year, BPMC TTM depreciation & amortization has changed by -$3.33 M (-19.41%)